Pfizer CEO proclaims the company is open to diverse methods of increasing business revenue.
Wired PR News.com – Pfizer CEO, Jeff Kindler, has stated the company is open to new prospects for increasing revenue. As reported by Reuters, Kindler remarked in an interview with the Financial Times that the company would consider acquisitions.
Kindler is quoted in the report as stating, “The real goal is to grow revenues … We are open to opportunities and constantly looking at those which are big, small and in-between.” The CEO further commented, “We will advance strategies to generate new and diverse sources of revenue growth and cost structures to position us to be strong after Lipitor.”
Pfizer is the largest pharmaceutical company in the world. As noted by Reuters, revenue decreases are anticipated in 2011 for one of the company’s top selling cholesterol medications, Lipitor, which generates $12 billion annually. The year will be the market release period for generic brands of the cholesterol drug.
